Bristol-Myers Squibb buy Truist Financial Co.
Start price
06.10.23
/
50%
€53.50
Target price
06.10.24
€79.27
Performance (%)
-8.08%
End price
07.10.24
€49.18
Summary
This prediction ended on 07.10.24 with a price of €49.18. With a performance of -8.08%, the BUY prediction for Bristol-Myers Squibb by Truist_Financial_Co_ closed slightly in the red. Truist_Financial_Co_ has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €2.20 are taken into consideration when calculating the performance. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 4.248% | 4.248% | -16.940% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.56
08.01.25
08.01.25
€63.06
08.01.26
08.01.26
-17.83%
20:00
20:00
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.60
15.09.23
15.09.23
€78.67
15.09.24
15.09.24
-20.88%
16.09.24
16.09.24